204 related articles for article (PubMed ID: 13309001)
21. [Clinical experience with the oral antidiabetic remedy invenol].
SCHNEEWEISS J; GASSMANN W; BUDING A
Arztl Wochensch; 1956 Mar; 11(12):266-8. PubMed ID: 13326744
[No Abstract] [Full Text] [Related]
22. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.
DIENGOTT D; DOLGER H; MIRSKY IA
Metabolism; 1956 Nov; 5(6 Part 2):875-93. PubMed ID: 13378057
[No Abstract] [Full Text] [Related]
23. Treatment of diabetes mellitus with BZ-55.
METZLER WS
Can Med Assoc J; 1956 Jun; 74(12):987-8. PubMed ID: 13329952
[No Abstract] [Full Text] [Related]
24. Treatment of diabetes mellitus with BZ-55.
CHARLES B
Can Med Assoc J; 1956 Jun; 74(12):985-7. PubMed ID: 13329951
[No Abstract] [Full Text] [Related]
25. [Critical study of the mechanism of action of the oral anti-diabetic agent, nadisan].
FRAENKEL KA; SCHULZ K
Dtsch Med J; 1956 Apr; 7(8):209-14. PubMed ID: 13344175
[No Abstract] [Full Text] [Related]
26. [Trial therapy of diabetes mellitus with BZ 55].
BOULIN R
Presse Med (1893); 1956 Apr; 64(28):643-5. PubMed ID: 13335854
[No Abstract] [Full Text] [Related]
27. Treatment of unstable diabetes mellitus with BZ-55 and insulin.
WATT JG
Can Med Assoc J; 1956 Jun; 74(12):983-5. PubMed ID: 13329950
[No Abstract] [Full Text] [Related]
28. D 860, a new antidiabetic remedy.
HEIKINHEIMO R
Duodecim; 1957; 73(1):53-5. PubMed ID: 13427681
[No Abstract] [Full Text] [Related]
29. [First results of the treatment of diabetes by BZ 55].
Klotz HP; Avril J; Israel L; Gorins L
Bull Mem Soc Med Hop Paris; 1956; 72(14-15):453-5. PubMed ID: 13342945
[No Abstract] [Full Text] [Related]
30. The effect of BZ-55 on biochemically uncontrolled diabetes without insulin treatment.
LEIBEL BS
Can Med Assoc J; 1956 Jun; 74(12):979-82. PubMed ID: 13329949
[No Abstract] [Full Text] [Related]
31. [Results and clinical aspects of new oral treatment of diabetes mellitus with N-butylsulfanilylurea BZ-55].
INTROZZI P; MARIGO S
Minerva Med; 1956 Jun; 47(50):1959-66. PubMed ID: 13348335
[No Abstract] [Full Text] [Related]
32. [Sulfamides, hypoglycaemic and antidiabetic].
Thomas J
Rev Prat; 1956 May; 6(14):1548-54. PubMed ID: 13336923
[No Abstract] [Full Text] [Related]
33. BZ 55 in diabetes.
MCKENZIE JM; MARSHALL PB; STOWERS JM; HUNTER RB
Br Med J; 1956 Aug; 2(4990):448-51. PubMed ID: 13342510
[No Abstract] [Full Text] [Related]
34. Treatment of diabetes with a new orally administered drug; preliminary report.
MASSOBRIO E; BOGLIONE G
Minerva Med; 1956 Jan; 47(9):273-6. PubMed ID: 13309002
[No Abstract] [Full Text] [Related]
35. Clinical response to BZ-55.
SPAULDING WB
Can Med Assoc J; 1956 Jun; 74(12):992-4. PubMed ID: 13329955
[No Abstract] [Full Text] [Related]
36. Preliminary experience with BZ-55.
HALL WE; LITTLE JA; O'SULLIVAN MO
Can Med Assoc J; 1956 Jun; 74(12):991-2. PubMed ID: 13329954
[No Abstract] [Full Text] [Related]
37. The value of BZ 55 in control of diabetes.
MURRAY I; WANG I
Br Med J; 1956 Aug; 2(4990):452-4. PubMed ID: 13342512
[No Abstract] [Full Text] [Related]
38. Effect of BZ-55 on the insulin tolerance curve.
SMITH GW; KUMAR D
Can Med Assoc J; 1956 Jun; 74(12):997. PubMed ID: 13329957
[No Abstract] [Full Text] [Related]
39. [Oral treatment of diabetes mellitus with D-860, a new hypoglycemic but not sulfonamidic drug; clinical study of 90 cases].
INTROZZI P; MARIGO S
Prog Med (Napoli); 1956 Sep; 12(17):513-27. PubMed ID: 13379550
[No Abstract] [Full Text] [Related]
40. [The current place of hypoglycemic sulfonamides (BZ 55) and similar products (D 860) in diabetic control].
BASTENIE PA
Brux Med; 1957 Mar; 37(13):499-506. PubMed ID: 13426651
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
